Edition:
United Kingdom

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

3.40USD
15 Dec 2017
Change (% chg)

$-0.09 (-2.58%)
Prev Close
$3.49
Open
$3.47
Day's High
$3.63
Day's Low
$3.40
Volume
113,813
Avg. Vol
69,471
52-wk High
$12.38
52-wk Low
$1.86

Select another date:

Fri, Nov 17 2017

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris

BRIEF-Amyris posts Q3 GAAP loss of $1.14 per share

* Amyris reports another strong quarter of product sales growth and expects strong finish for 2017

BRIEF-Amyris files for offering of up to 26.2 mln shares of common stock by selling stockholders‍​

* Amyris Inc files for offering of up to 26.2 million shares of common stock by the selling stockholders - SEC filing ‍​ Source text: (http://bit.ly/2zaU4Od) Further company coverage:

BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.

* Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient

BRIEF-Amyris enters into second major product development with Royal DSM

* Amyris Inc enters into second major product development and production agreement with Royal DSM

BRIEF-Amyris Q2 loss per share $0.46

* Amyris delivers another strong quarter with revenue of $25.7 million and product sales increase of 159% over 2nd quarter of 2016

BRIEF-Vivo Capital VIII reports 9.9 pct stake in Amyris

* Vivo Capital VIII LLC reports 9.9 percent passive stake in Amyris Inc as of August 2, 2017 - SEC filing Source text: (http://bit.ly/2vCkff7) Further company coverage:

BRIEF-Amyris files for offer and sale of up to 42.27 mln shares

* Amyris Inc files for offer and sale of up to 42.27 million shares of co's common stock by the selling stockholders - sec filing‍​ Source text: (http://bit.ly/2hwaLw0) Further company coverage:

BRIEF-Amyris says second tranche of $50 mln in a private placement days is being led by a $25-mln investment from Koninklijke​

* Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million

BRIEF-Amyris enters into first product development, production agreement with Royal DSM

* Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule

Select another date: